HomeALCOX • EPA
add
NicOx SA
Nakaraang pagsara
€0.30
Sakop ng araw
€0.30 - €0.32
Sakop ng taon
€0.14 - €0.49
Market cap
21.11M EUR
Average na Volume
200.70K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Hun 2023info | Y/Y na pagbabago |
|---|---|---|
Kita | 866.50K | — |
Gastos sa pagpapatakbo | 1.75M | — |
Net na kita | -3.30M | — |
Net profit margin | -381.19 | — |
Kita sa bawat share | — | — |
EBITDA | -4.17M | — |
Aktuwal na % ng binabayarang buwis | -0.30% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Hun 2023info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 19.01M | — |
Kabuuang asset | 82.28M | — |
Kabuuang sagutin | 36.75M | — |
Kabuuang equity | 45.53M | — |
Natitirang share | 50.15M | — |
Presyo para makapag-book | 0.33 | — |
Return on assets | -12.84% | — |
Return on capital | -15.84% | — |
Cash Flow
Net change in cash
| (EUR) | Hun 2023info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -3.30M | — |
Cash mula sa mga operasyon | -4.16M | — |
Cash mula sa pag-invest | -19.50K | — |
Cash mula sa financing | -135.00K | — |
Net change in cash | -4.32M | — |
Malayang cash flow | -2.86M | — |
Tungkol
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
Itinatag
1996
Headquarters
Website
Mga Empleyado
5
